Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy

Advances in ex vivo technologies of human genome editing have made it possible to develop new approaches to the treatment of genetic, oncological, infectious and other diseases, which may involve the use of biomedical cell products. However, despite the rapid development of these technologies and a...

Full description

Bibliographic Details
Main Authors: A. A. Goryaev, M. V. Savkina, K. M. Mefed, V. P. Bondarev, V. A. Merkulov, V. V. Tarasov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-09-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
zfn
Online Access:https://www.biopreparations.ru/jour/article/view/169